Document is current
Any future updates will be listed below
-
Authors
Chan, Tsz Him
Haworth, Annette
Wang, Alan
Osanlouy, Mahyar
Williams, Scott
Mitchell, Catherine
Hofman, Michael S.
Hicks, Rodney J.
Murphy, Declan G.
Reynolds, Hayley M. https://orcid.org/0000-0001-8146-1113
-
Funding
Funding for this research was provided by:
Prostate Cancer Foundation of Australia (YI 0513)
Health Research Council of New Zealand (20/017)
National Health and Medical Research Council (1126955)
- License Information
-
More Information
Article History
Received: 7 March 2023
Accepted: 17 April 2023
First Online: 26 April 2023
Declarations
:
: Ethics approval was obtained from the Peter MacCallum Cancer Centre Human Research Ethics Committee (HREC/15/PMCC125). This study was performed in accordance with the ethical standards as laid down in the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. All patients provided written informed consent.
: All patients provided written informed consent to allow publication of their deidentified data.
: AH has a non-financial research agreement with Siemens Healthineers which does not relate to the current work. MSH acknowledges research grant support from Novartis (including AAA and Endocyte), ANSTO, Bayer and Isotopia. Consulting fees for lectures or advisory boards from Astellas, AstraZeneca, Janssen, Merck/MSD, Mundipharma and Point Biopharma. RJH is a shareholder in Telix Pharmaceuticals. All other authors declare no competing interests.
